Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
28.19 CNY
1.48%
Market Closed
Updated:
Jun 9, 2024
Beijing Hotgen Biotech Co Ltd
Cash & Cash Equivalents
|
Beijing Hotgen Biotech Co Ltd
Cash & Cash Equivalents Peer Comparison
Comparables:
603259
300759
2269
300347
M
688114
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Cash & Cash Equivalents
¥272.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash & Cash Equivalents
¥10B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash & Cash Equivalents
¥5.8B
|
CAGR 3-Years
38%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash & Cash Equivalents
¥9.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash & Cash Equivalents
¥7.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
60%
|
CAGR 10-Years
33%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash & Cash Equivalents
¥6.5B
|
CAGR 3-Years
371%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
272.4m
CNY
272.4m
CNY
Based on the financial report for Dec 31, 2023, Beijing Hotgen Biotech Co Ltd's Cash & Cash Equivalents amounts to 272.4m CNY.
What is Beijing Hotgen Biotech Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
34%
34%
Over the last year, the Cash & Cash Equivalents growth was -48%. The average annual Cash & Cash Equivalents growth rates for Beijing Hotgen Biotech Co Ltd have been -11% over the past three years , 34% over the past five years .
You don't have any saved screeners yet
